Close Menu

Promega

NEW YORK (GenomeWeb News) – Life Technologies last week filed a lawsuit against Promega alleging infringement of a US patent covering oligonucleotide labeling methods and compositions.

Tecan and Promega this week introduced a fully automated workstation for extracting genomic DNA from whole blood samples.

NEW YORK (GenomeWeb News) – Exosome Diagnostics today said that Promega will be the exclusive supplier of its Urine Clinical Sample Concentrator Kit, which incorporates Exosome's technology for concentration of urinary exosomes.

In 2005, scientists from two Spanish research institutions published a paper in Cancer Research reporting the spontaneous transformation of human adult stem cells to cancer stem cells — the first time, they asserted, that such a phenomenon had been reported.

Promega has launched the PowerPlex Fusion System, a 24-locus multiplex assay that incorporates common and informative loci used throughout the world.

A study published this week provides the most definitive evidence to date disproving previous reports that used molecular testing methods such as qPCR to establish a link between chronic fatigue syndrome, or myalgic encephalomyelitis, and various murine leukemia viruses.

Life Technologies this week launched the next generation of its STR analysis kits for human identification and forensic applications, the GlobalFiler and GlobalFiler Express.

NEW YORK (GenomeWeb News) – A federal judge has overturned a jury's decision to award Promega $52 million in damages in a patent infringement lawsuit the Madison, Wis.-based firm had filed against Life Technologies.

City of Hope has been awarded US Patent No. 8,227,191, "Method for amplification and detection of RNA sequences."
George Murakawa, Bruce Wallace, John Zaia, and John Rossi are named as inventors on the patent.

Illumina has launched its Nextera Exome and Custom Enrichment Kits for sample preparation for next-gen sequencing.

Pages

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.